Stanley Laman Group, Ltd. Guardant Health, Inc. Transaction History

Stanley Laman Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$28.82 - $77.35 $25,246 - $67,758	-876 Reduced 3.21%	26,448 $1.07 Million
Q1 2022 Apr 21, 2022	BUY	$48.25 - $100.49 $456,782 - $951,338	9,467 Added 53.02%	27,324 $1.81 Million
Q4 2021 Jan 25, 2022	BUY	$88.71 - $120.43 $1.11 Million - $1.51 Million	12,507 Added 233.78%	17,857 $1.79 Million
Q3 2021 Nov 03, 2021	BUY	$98.77 - $132.17 $528,419 - $707,109	5,350 New	5,350 $669,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.